RxDoctor Payments Data

Penny Hunsberger, NP

Gerontology · Crawfordsville, INNPI 1376029728

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (48.7%), food and beverage and education — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Boston Scientific at 40.0% of the total. 2025 is the largest year on record at $2,010, more than ten times the $157 reported in 2022. Among gerontology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,179in general payments, 2019–2025

Across 54 payments — averaging $77.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Abbott$1K
  • Edwards Lifesciences$662
  • AstraZeneca$348
  • Heartflow, Inc.$34
  • Novartis$27
  • plus $31 from 2 others

What the payments were for

  • Consulting fees$2005%
  • Travel & lodging$2,03549%
  • Food & beverage$1,73041%
  • Education$2145%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,179 in reported general payments places this provider in the 90th percentile of 230 gerontology providers in Indiana.

See all gerontology providers in Indiana

Medicare billing

Part B allowed, 2024
$85,723
Medicare patients
524
Services billed
870

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban541$586,470
FarxigaDapagliflozin Propanediol370$327,800
EntrestoSacubitril/Valsartan250$290,887
JardianceEmpagliflozin138$155,489
XareltoRivaroxaban86$94,722
NexletolBempedoic Acid34$25,125
DapagliflozinDapagliflozin Propanediol34$17,789
Ezetimibe227$7,634
Metoprolol Succinate507$5,706
Atorvastatin Calcium542$5,055
Diltiazem 24hr Er (Cd)Diltiazem Hcl172$4,503
Digoxin99$3,176
Flecainide Acetate79$3,161
Spironolactone348$3,146
Rosuvastatin Calcium141$2,508

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$21$586,470541 claims
AstraZenecaFarxiga$348$327,800370 claims
NovartisEntresto$27$290,887250 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 230 gerontology providers in Indiana.

Other gerontology in Crawfordsville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →